Takuro Okada

1.2k total citations
72 papers, 540 citations indexed

About

Takuro Okada is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Takuro Okada has authored 72 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 25 papers in Oncology and 20 papers in Otorhinolaryngology. Recurrent topics in Takuro Okada's work include Head and Neck Cancer Studies (20 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Salivary Gland Tumors Diagnosis and Treatment (10 papers). Takuro Okada is often cited by papers focused on Head and Neck Cancer Studies (20 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Salivary Gland Tumors Diagnosis and Treatment (10 papers). Takuro Okada collaborates with scholars based in Japan and China. Takuro Okada's co-authors include Kiyoaki Tsukahara, Isaku Okamoto, Hiroki Sato, Chihiro Fushimi, M Matsuno, Kouki Miura, Takashi Matsuki, Takahito Kondo, Taku Yamashita and Go Omura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biotechnology and Bioengineering.

In The Last Decade

Takuro Okada

63 papers receiving 518 citations

Peers

Takuro Okada

PRM

ONCOL

OTORH

SURGE

PHYSI

Brandon Greene Germany

Giovanni Motta Italy

Atul Sharma India

Danny Svane Denmark

Ashok Poluri United States

Natasha Cohen Canada

Nobutaka Kitamura Japan

Sharon J. Allan Canada

Brett Klamer United States

Jian Zou China

Brandon Greene Germany

Takuro Okada

113 ×0.5

PRM

162 ×0.7

ONCOL

133 ×0.9

OTORH

217 ×1.7

SURGE

28 ×0.4

PHYSI

Citations per year, relative to Takuro Okada Takuro Okada (= 1×) peers Brandon Greene

Countries citing papers authored by Takuro Okada

Since Specialization

Citations

This map shows the geographic impact of Takuro Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuro Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuro Okada more than expected).

Fields of papers citing papers by Takuro Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuro Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuro Okada. The network helps show where Takuro Okada may publish in the future.

Co-authorship network of co-authors of Takuro Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Takuro Okada. A scholar is included among the top collaborators of Takuro Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuro Okada. Takuro Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okada, Takuro, et al.. (2024). Renal Immune-Related Adverse Event Difficult to Diagnose during Nivolumab Treatment for Hypopharyngeal Carcinoma: Case Report. SHILAP Revista de lepidopterología. 17(1). 966–972.

Matsuki, Takashi, Takuro Okada, Chihiro Fushimi, et al.. (2024). Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab. Anticancer Research. 44(9). 4057–4072. 2 indexed citations

Okamoto, Isaku, et al.. (2024). Two Cases of Emergency Tracheostomy After Head and Neck Photoimmunotherapy. Cancer Diagnosis & Prognosis. 4(1). 85–90. 7 indexed citations

Okamoto, Isaku, et al.. (2024). Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer. Anticancer Research. 44(9). 4085–4092.

Okada, Takuro, Chihiro Fushimi, Takashi Matsuki, et al.. (2023). Effects of Pembrolizumab in Recurrent/Metastatic Squamous Cell Head and Neck Carcinoma: A Multicenter Retrospective Study. Anticancer Research. 43(6). 2717–2724. 5 indexed citations

Okada, Takuro, Masayuki Hashiguchi, & Satoko Hori. (2022). Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance. International Journal of Clinical Pharmacy. 44(6). 1332–1341.

Okamoto, Isaku, et al.. (2022). A Case Treated With Photoimmunotherapy Under a Navigation System for Recurrent Lesions of the Lateral Pterygoid Muscle. In Vivo. 36(2). 1035–1040. 17 indexed citations

Ito, Tatsuya, Isaku Okamoto, Hiroki Sato, et al.. (2022). PD-L1 Expression and Survival Rates Using TPS and CPS for Nivolumab-treated Head-and-Neck Cancer. Anticancer Research. 42(3). 1547–1554. 15 indexed citations

Okamoto, Isaku, et al.. (2022). A Case of Recurrent Metastatic Parotid Acinic Cell Carcinoma Responsive to Pembrolizumab. In Vivo. 36(2). 1047–1051.

10.

Okamoto, Isaku, et al.. (2021). Postoperative Complications of Jejunal and Skin Valve Reconstruction in Free Reconstructive Surgery for Hypopharyngeal Carcinoma. Anticancer Research. 41(8). 4033–4038. 3 indexed citations

11.

Okamoto, Isaku, et al.. (2021). Pericardial metastasis of parotid mucoepidermoid carcinoma diagnosed by pericardial biopsy. Auris Nasus Larynx. 49(4). 727–732. 2 indexed citations

12.

Okada, Takuro, et al.. (2021). Efficacy and Safety of Paclitaxel Combined With Cetuximab for Head and Neck Squamous Cell Carcinoma. In Vivo. 35(2). 1253–1259. 12 indexed citations

13.

Sato, Hiroki, Chihiro Fushimi, Takuro Okada, et al.. (2020). Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma. In Vivo. 34(5). 2967–2972. 12 indexed citations

14.

Fushimi, Chihiro, Isaku Okamoto, Takashi Matsuki, et al.. (2020). Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma. Anticancer Research. 40(9). 5277–5283. 23 indexed citations

15.

Okada, Takuro, Takashi Saotome, Toshitaka Nagao, et al.. (2019). Carboplatin and Docetaxel in Patients With Salivary Gland Carcinoma: A Retrospective Study. In Vivo. 33(3). 843–853. 16 indexed citations

16.

Okada, Takuro, Masahito Nakazaki, Masateru Ito, et al.. (2017). Evaluation Criteria for Clinical Usefulness of Generic Transdermal Adhesive Agents. 19(3). 104–110.

17.

Tsukahara, Kiyoaki, et al.. (2017). Extent of thyroid resection and thyroid function after postoperative radiotherapy following total laryngectomy or total pharyngo-laryngo-esophagectomy. International Journal of Clinical Oncology. 22(3). 438–441. 9 indexed citations

18.

Okada, Takuro, et al.. (2012). A Case of Spindle Cell Lipoma of the Arytenoid. Practica Oto-Rhino-Laryngologica. 105(10). 969–972. 1 indexed citations

19.

Nakamura, Kazuhiro, Kiyoaki Tsukahara, Tomoyuki Yoshida, et al.. (2010). A Device that Allows an Operator to Perform Arytenoid Adduction without Assistance. Nihon Kikan Shokudoka Gakkai Kaiho. 61(4). 368–374. 1 indexed citations

20.

Igarashi, Takao, et al.. (1987). [Clinical features of bronchial asthma induced by chironomid midges. Mass screening of asthmatic children by a radioallergosorbent test on Chironomus plumosus].. PubMed. 36(12). 1054–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact